Rockville, MD, United States of America

Stephen D Wolfe

This inventor holds 1 USPTO granted patent. Top assignee: Wellstat Therapeutics Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen D Wolfe. Retrieved from https://idiyas.com/inventor/stephen-d-wolfe-hor0o3p0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen D. Wolfe

Introduction

Stephen D. Wolfe is an accomplished inventor based in Rockville, MD (US). He has made significant contributions to the field of stem cell research, particularly in the area of stem cell proliferation. His work has the potential to impact therapies related to chemotherapy recovery.

Latest Patents

Stephen D. Wolfe holds a patent titled "Inhibitor of Stem Cell Proliferation and Uses Thereof." This patent discloses and claims methods for isolating and utilizing stem cell inhibiting factors. These methods are aimed at regulating the abnormal stem cell cycle and accelerating the recovery of peripheral blood cells following chemotherapy. Additionally, the patent includes claims for the inhibitors of stem cell proliferation.

Career Highlights

Stephen is currently associated with Wellstat Therapeutics Corporation, where he continues to advance his research and innovations. His work at the company focuses on developing therapeutic solutions that leverage his expertise in stem cell biology.

Collaborations

Stephen collaborates with Irena Tsyrlova, contributing to the advancement of their shared research goals.

Conclusion

Stephen D. Wolfe's innovative work in stem cell research exemplifies the impact of dedicated inventors in the medical field. His contributions are paving the way for improved recovery methods for patients undergoing chemotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…